After MPs Reject Brexit Deal, UK ABPI Wants Solution 'Quickly'
Following the government’s defeat over the Brexit withdrawal deal, the life sciences industry wants the UK parliament to find a solution quickly to avoid a “no-deal” scenario.
You may also be interested in...
Pharmaceutical industry bodies are exasperated by the lack of detail in the UK government’s update on contingency planning for the supply of medicines in the event of a no-deal Brexit.
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.